Cytek Biosciences Inc
(FRA:8EQ)
€
5.75
0.15 (2.68%)
Market Cap: 802.24 Mil
Enterprise Value: 567.61 Mil
PE Ratio: 0
PB Ratio: 2.12
GF Score: 62/100 - Q1 2024 Cytek Biosciences Inc Earnings Call TranscriptMay 08, 2024€5.85 (-0.85%)Earnings
- Q4 2023 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2024€3.4Earnings
- Cytek Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Cytek Biosciences Inc Earnings Call TranscriptNov 07, 2023€4 (-0.50%)Earnings
- Cytek Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Cytek Biosciences Inc Earnings Call TranscriptAug 08, 2023€8.2Earnings
- Cytek Biosciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Cytek Biosciences Inc Earnings Call TranscriptMay 09, 2023€10.4 (-1.89%)Earnings
- Q4 2022 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2023€9.85 (-5.29%)Earnings
- Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call TranscriptFeb 13, 2023
- Cytek Biosciences Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Cytek Biosciences Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Cytek Biosciences Inc Earnings Call TranscriptNov 09, 2022€14.2 (-2.07%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Cytek Biosciences Inc Earnings Call TranscriptAug 10, 2022€14.2 (-2.07%)Earnings
- Cytek Biosciences Inc Corporate Analyst Meeting TranscriptJun 22, 2022
- Q1 2022 Cytek Biosciences Inc Earnings Call TranscriptMay 11, 2022€7.5 (+2.74%)Earnings
- Q4 2021 Cytek Biosciences Inc Earnings Call TranscriptFeb 23, 2022€11.7 (-4.10%)Earnings
- Q3 2021 Cytek Biosciences Inc Earnings Call TranscriptNov 08, 2021€21 (+1.94%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023 / 08:15PM GMT
Release Date Price:
€6.65
(+3.91%)
Yih;Ming Tu
Morgan Stanley, Research Division - Research Associate
Good afternoon, everyone. Welcome to day 3 of our Morgan Stanley Global Healthcare Conference. My name is Edmund Tu. I work on the life science tools team here at MS.
Before we begin, I want to remind everyone important disclosures can be found at morganstanley.com/researchdisclosures. And it's my pleasure to be hosting Cytek Biosciences today. And on-stage representing the company, I have Wenbin Jiang, CEO; and Patrik Jeanmonod, CFO. Thank you guys for coming and welcome.
Wenbin Jiang
Cytek Biosciences, Inc. - President, CEO & Chairman of the Board
Thank you.
Patrik Sebastian Jeanmonod
Cytek Biosciences, Inc. - CFO
Thank you.
Questions & Answers
Yih;Ming Tu
Morgan Stanley, Research Division - Research Associate
I guess to start, Wenbin. Can you talk about what you think is Cytek's key accomplishments over the past 12 months? What were some
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)